FdaApplication
BLA 761123
Identifiers
- fda_app_no: BLA761123
Properties
| Property | Value |
|---|---|
| applicant_name | AstraZeneca AB |
| application_type | BLA |
| approval_date | 2021-07-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SAPHNELO | ANIFROLUMAB-FNIA | 300MG/2ML (150MG/ML) | Injection |
1 product